JUN and cancer: We subsequently demonstrated that JNK/c-Jun signaling activation markedly increased PD-L1 expression in parental cancer cells, while JNK/c-Jun signaling inhibition dramatically decreased PD-L1 expression in their drug-resistant counterparts.